Back to Stakeholders
Categories

1 domain / 2 areas / 1 specialization

Vine Ventures

Data updated

New York, NY, United States

Vine Ventures is an early-stage venture capital firm that describes its work as focused on health and wellness, with a particular interest in psychedelics, mental health, consciousness, and related life sciences themes. The firm says it was started in 2020 and operates with a presence in New York City and Tel Aviv.

In the psychedelic ecosystem, Vine has positioned itself as a backer of companies and initiatives tied to psychedelic therapies and adjacent mental health models. Its public materials say it has led a large financing vehicle for MAPS to help bring MDMA to market for PTSD and that its team publishes and hosts content around psychedelic science and distribution.

Investor Context

Venture Capital

Investment Context

This stakeholder is listed as a Venture Capital Fund within Venture Capital. Its public geography context is global. Public stage signals include Seed, Series A/B, and Growth / Late Stage. Public focus areas include Drug Development.

Public Portfolio Examples

  • MAPSSPV / private financing - almost $45M

Vine Ventures presents itself as a founder-facing, early-stage investor focused on novel approaches to mental health, wellbeing, and psychedelic-enabled care. The firm says it has invested across early-stage companies in the space and that its broader thesis includes supporting sustainable rollout of psychedelic therapies alongside adjacent models such as breathwork, community-based wellness, and neurotechnology. Its public content emphasizes hands-on support, a global lens, and an explicit connection to psychedelic investing through both direct company investments and ecosystem financing.

Investor Type

Venture Capital Fund

Geographic Scope

Global

Psychedelic Focus

Psychedelic-Adjacent Focus

Engagement

Active

Investment Stage Focus

SeedSeries A/BGrowth / Late Stage

Investment Focus Areas

Drug Development

Investment Orientation

Engagement Status

Active

Investor Type

Venture Capital Fund

Investment Website

Recorded Investments

MAPS

Date unknown

SPV / private financing - almost $45M

Vine says it led a regenerative financing SPV to help MAPS bring MDMA to market for PTSD.

Vine Ventures: The Next Chapter

Quick Facts

Founded
2020
HQ
New York, NY, United States
Website
Visit